Summary
The uptake and metabolism of 3H-noradrenaline has been examined in the FL cell-line derived originally from human amnion. Cell cultures metabolised 3H-noradrenaline (1.0 μmol/l) to 3H-normetanephrine and, to a lesser extent, to metabolites (not distinguished) of the O-methylated deaminated fraction; primary deaminated metabolites were not detected.
3(H-normetanephrine formation a) was not saturable in the noradrenaline concentration range 0.2–150 μmol/l, b was decreased to 20%–30% of control levels by uptake2 inhibitors (O-methylisoprenaline, 20 and 100 μmol/l; cimetidine, 10 μmol/l; hydrocortisone, 200 μmol/l) and c, was almost insensitive to uptake1 inhibitors (cocaine, 30 μmol/l; desipramine, 3 μmol/l).
Uptake of noradrenaline was manifested after 30 minutes as a 6-fold increase in the cell content of the amine following inhibition of catechol-O-methyl transferase, either alone or in conjunction with inhibition of monoamine oxidase. Uptake was decreased maximally to 40% of control levels by O-methylisoprenaline. IC50 values for inhibition of the O-methylisoprenaline-sensitive component of uptake were (in μmol/l): corticosterone (0.3), papaverine (1.1), O-methylisoprenaline (3.0), cimetidine (6.0), (−)noradrenaline (460), and tetraethylammonium (2230). Except for the last agent, for which a comparative value is not available, the IC50's are in good agreement with those for inhibition of uptake2 in the Caki-1 cell-line reported by other investigators.
The component of uptake resistant to O-methylisoprenaline was depressed by papaverine (a 50% decrease at 50 μmol/l), but was not affected by the other uptake2 inhibitors or by cocaine (30 μmol/l).
It is concluded that the FL cell possesses an extraneuronal metabolising system very similar to the system in tissues such as heart and smooth muscle where transport of noradrenaline into the cell by uptake2 is followed by rapid O-methylation via catechol-O-methyl transferase. The only difference appears to be the absence of saturation of 3H-normetanephrine formation in the FL cell at low micromolar concentrations of 3H-noradrenaline. The presence of a second uptake process is suggested by the inhibitory effect of papaverine on uptake resistant to O-methylisoprenaline; lack of effect of cocaine implies that this second process is not uptake,.
Similar content being viewed by others
Abbreviations
- COMT:
-
catechol-O-methyl transferase
- DOMA:
-
dihydroxymandelic acid
- DOPEG:
-
dihydroxyphenylethylene glycol
- MAO:
-
monoamine oxidase
- NMN:
-
normetanephrine
- OMDA:
-
O-methylated and deaminated metabolite fraction
- OMI:
-
3-O-methylisoprenaline
- TEA:
-
tetraethylammonium
References
de la Lande IS, Marino V, Lavranos T, Kennedy JA, Parker DAS, Seamark RF (1991) Distribution of extraneuronal uptake, in reproductive tissues: studies on cells in culture. J Neural Transm [Suppl]34:37–42
Graefe K-H, Stefano FJE, Langer SZ (1973) Preferential metabolism of 3H-(−)-noradrenaline through the deaminated glycol in the rat vas deferens. Biochem Pharmacol 22:1147–1160
Grohmann M, Trendelenburg U (1984) The substrate specificity of uptake2 in the rat heart. Naunyn Schmiedeberg's Arch Pharmacol 328:164–173
Kennedy JA, de la Lande IS (1986) Effect of progesterone on the metabolism of noradrenaline in the rabbit uterine endometrium and myometrium. Naunyn Schmiedeberg's Arch Pharmacol 333:368–376
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275
Phillippe M (1983) Fetal catecholamines. Am J Obstet Gynecol 146:840–853
Phillippe M, Niloff JM (1982) Metabolism of 3H-dopamine by human chorioamnion in vitro. Am J Obstet Gynecol 143:782–787
Reid JJ, Stitzel RE, Head RJ (1986) Characterization of the O-methylation of catechol oestrogens by intact rabbit thoracic aorta and subcellular fractions thereof. Naunyn Schmiedeberg's Arch Pharmacol 334:17–28
Saarikoski S (1974) Fate of noradrenaline in the human foetoplacental unit. Acta Physiol Scand [Suppl] 421:1–78
Schömig E, Schonfeld C-L (1990) Extraneuronal noradrenaline transport (uptake2) in a human cell line (Caki-1 cells). Naunyn Schmiedeberg's Arch Pharmacol 341:404–410
Schömig E, Babin-Ebell J, Gliese M, Russ H (1991) Extraneuronal inactivation of noradrenaline in tissue culture. J Neural Transm [Suppl] 34:43–49
Trendelenburg U (1980) A kinetic analysis of extraneuronal uptake and metabolism of catecholamines. Rev Physiol Biochem Pharmacol 87:33–115
Trendelenburg U (1984) Metabolizing systems. In: Fleming WW et al (eds) Neuronal and extraneuronal events in autonomic pharmacology. Raven Press, New York, pp 93–109
Trendelenburg U (1988) The extraneuronal uptake and metabolism of catecholamines. In: Trendelenburg U, Weiner N (eds) Handbook of Experimental Pharmacology, vol 90/1. Springer, Heidelberg Berlin New York, pp 279–319
Youdim MBH, Finberg JPM, Tipton KF (1988) Monoamine oxidase. In: Trendelenburg U, Weiner N (eds) Handbook of Experimental Pharmacology, vol 90/1. Springer, Heidelberg Berlin New York, pp 119–192
Author information
Authors and Affiliations
Additional information
Correspondence to I. S. de la Lande at the above address
Rights and permissions
About this article
Cite this article
Marino, V., de la Lande, I.S., Newlyn, M. et al. Evidence for uptake2-mediated O-methylation of noradrenaline in the human amnion FL cell-line. Naunyn-Schmiedeberg's Arch Pharmacol 347, 371–378 (1993). https://doi.org/10.1007/BF00165386
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00165386